Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05428969
What this trial is testing

Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Faron Pharmaceuticals Ltd 181
Early research (Phase 1)Not Yet RecruitingNCT07722767
What this trial is testing

A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients

Who this might be right for
AML (Acute Myeloid Leukemia)
Cullinan Therapeutics Inc. 90
Large-scale testing (Phase 3)UnknownNCT05457361
What this trial is testing

VAH Versus VA for Salvage Therapy of R/R-AML

Who this might be right for
Venetoclax Combined With Azacitidine Plus HomoharringtonineVenetoclax Combined With Azacitidine
Nanfang Hospital, Southern Medical University 162
Not applicableNot Yet RecruitingNCT06841952
What this trial is testing

Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia

Who this might be right for
AML, Adult
The First Affiliated Hospital of Soochow University 158
Testing effectiveness (Phase 2)UnknownNCT04809181
What this trial is testing

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University 95
Large-scale testing (Phase 3)Looking for participantsNCT07255872
What this trial is testing

BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd. 216
Testing effectiveness (Phase 2)Looking for participantsNCT07028086
What this trial is testing

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Who this might be right for
Acute Myeloid LeukemiaMyeloid Sarcoma
Ruijin Hospital 48
Testing effectiveness (Phase 2)Ended earlyNCT04752163
What this trial is testing

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+6 more
M.D. Anderson Cancer Center 17
Early research (Phase 1)Temporarily pausedNCT06514261
What this trial is testing

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT07672262
What this trial is testing

VA Consolidation in Intermediate-Risk AML

Who this might be right for
Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid LeukemiaConsolidation Therapy
The First Affiliated Hospital of Soochow University 226
Testing effectiveness (Phase 2)Active Not RecruitingNCT06456463
What this trial is testing

Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Stemline Therapeutics, Inc. 85
Early research (Phase 1)Study completedNCT04214860
What this trial is testing

APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies

Who this might be right for
Myeloid Malignancy
Aprea Therapeutics 51
Large-scale testing (Phase 3)Looking for participantsNCT06652438
What this trial is testing

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Who this might be right for
Acute Myeloid Leukemia, Adult
Stichting Hemato-Oncologie voor Volwassenen Nederland 448
Testing effectiveness (Phase 2)Active Not RecruitingNCT05782127
What this trial is testing

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

Who this might be right for
Untreated Myelodysplastic Syndrome
Groupe Francophone des Myelodysplasies 36
Early research (Phase 1)Study completedNCT05155709
What this trial is testing

Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Ended earlyNCT04161885
What this trial is testing

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Cancer
AbbVie 465
Early research (Phase 1)Ended earlyNCT04748848
What this trial is testing

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Who this might be right for
Leukemia, Myeloid
Celgene 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Early research (Phase 1)Ended earlyNCT04912063
What this trial is testing

Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
AbbVie 40
Large-scale testing (Phase 3)Study completedNCT03941964
What this trial is testing

The Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)Cancer
AbbVie 60
Next Page